In the September 2025 quarter, Biocons generics business grew 24% year-on-year to 774 crore, with margins on its biosimilars near-copies of complex biological drugs expanding to 28% at the operating-profit (EBITDA) level
Tirzepatide is sometimes referred to as the next step after GLP-1 treatments, making patients think its a GLP-2 medication
By activating these dual pathways, tirzepatide enhances the bodys ability to control hunger, leading to more effective and sustained weight loss
How do I feel in the dress
If you remember after 3 days have passed, inject immediately, then resume your normal weekly schedule from that new date
Andrs E, Zulfiqar AA, Vogel T QJM : monthly journal of the Association of Physicians 2020